
Barry A Borlaug MD
Heart Failure & Transplantation
Associate Professor, Internal Medicine, Mayo Medical School
Join to view full profile
200 1st St SwRochester, MN 55905
Phone+1 507-284-2511
Dr. Borlaug is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- After graduating from medical school at the University of Wisconsin, Dr. Borlaug trained in internal medicine at the Brigham and Women’s Hospital in Boston, Massachusetts and cardiovascular medicine at the Johns Hopkins Hospital in Baltimore, Maryland prior to joining the cardiovascular division of the Mayo Clinic in Rochester, Minnesota where he is currently Associate Professor of Medicine and Director of Circulatory Failure research. Dr. Borlaug’s research interests focus on the pathophysiology, diagnosis and treatment of heart failure, particularly heart failure with preserved ejection fraction, with an emphasis on hemodynamics. He has published over 80 articles in peer reviewed journals on these topics. Dr. Borlaug is an active member of the American College of Cardiology, American Heart Association, Heart Failure Society of America, International Society for Heart and Lung Transplantation, and the Society of Cardiac Angiographers and Interventionalists.
Education & Training
Johns Hopkins UniversityFellowship, Cardiovascular Disease, 2002 - 2005
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1999 - 2002
University of Wisconsin School of Medicine & Public HealthClass of 1999
Certifications & Licensure
MN State Medical License 2006 - 2027
WI State Medical License 2014 - 2017
PA State Medical License 2005 - 2006
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Centricity Patient Online, GE Healthcare, 2014-2017
- CMS Meaningful Use Stage 2 Certification Mayo Clinic Electronic Notes, Mayo Clinic, 2014-2017
- CMS Meaningful Use Stage 1 Certification Centricity Enterprise (CE), GE Healthcare, 2014-2017
Clinical Trials
Publications & Presentations
PubMed
- Impact of systemic inflammation on exercise haemodynamics in unexplained dyspnoea and heart failure with preserved ejection fraction.Giulio M Mondellini, Jannik Heemann, Xavier Galloo, Daniele Plein, Lucie Soens
Acta Cardiologica. 2026-08-24 - Severe Infections as a Novel Risk-Enhancing Factor for Incident Heart Failure.Ryan T Demmer, Brandon R Grossardt, Sadiya S Khan, Barry A Borlaug
Journal of the American Heart Association. 2026-08-20 - What Are Heart Failure With Preserved Ejection Fraction Mimics and What Are They Mimicking? Insights Into Our Conceptualization of Heart Failure With Preserved Ejectio...Milton Packer, Javed Butler, Jennifer E Ho, Carolyn S P Lam, Mark C Petrie
Journal of Cardiac Failure. 2026-08-01
Journal Articles
- Application of Diagnostic Algorithms for Heart Failure with Preserved Ejection Fraction to the CommunityDalane W Kitzman, Barry A Borlaug, Amil M Shah, JACC: Heart Failure
- Clinical Research Central and Peripheral Determinants of Exercise Capacity in Heart Failure Patients with Preserved Ejection FractionSanjiv J Shah, Dalane W Kitzman, Barry A Borlaug, Daniel Burkhoff, ScienceDirect
- Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients with Heart Failure with Preserved Ejection FractionGregory D Lewis, David J Whellan, Martin M LeWinter, Margaret M Redfield, Andrew L Smith, Eugene Braunwald, Michael M Givertz, Adrian F Hernandez, Sanjiv J Shah, Horng..., JAMA
Lectures
- HFpEF: Why Is My Patient Huffing and Puffing? How Can We Help?2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
- The Connection Between Obesity and HFpEF: More Than What Meets the Eye?2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
- Exercise Hemodynamics: When to Test and What Do the Numbers Mean?2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
Other
- Editorial Comment the Other Atrium in Heart Failure∗Barry Borlaug, MD, ScienceDirect
https://www.doximity.com/articles/14c98790-28ea-42e1-94b3-874d1c080933
UpToDate, Wolters Kluwer Health - 2012-07-25 - Clinical Research Hemodynamic Correlates and Diagnostic Role of Cardiopulmonary Exercise Testing in Heart Failure with Preserved Ejection FractionBarry Borlaug, MD, ScienceDirect
https://www.doximity.com/articles/a2b890ed-e92c-4eed-bb94-5dffc2d16d21
UpToDate, Wolters Kluwer Health - 2012-11-21
Authored Content
- Application of Diagnostic Algorithms for Heart Failure with Preserved Ejection Fraction to the CommunityJuly 2020
- Application of Diagnostic Algorithms for Heart Failure with Preserved Ejection Fraction to the CommunityJune 2020
- Invasive and Noninvasive Hemodynamic Assessment in Adults with Fontan PalliationDecember 2017
Press Mentions
Oral GLP-1s Provide Benefit in HF Patients: SOUL SubanalysisFebruary 6th, 2026
Behind the Science: Tricuspid Regurgitation in HFpEF | JACCDecember 8th, 2025
SUMMIT Analysis: Does BMI and Central Adiposity Affect Tirzepatide Outcomes for HFpEF?July 22nd, 2025
Grant Support
- CardiovasologyMAYO CLINIC ROCHESTER1975–2030
- Pulmonary Hypertension in Left Heart DiseaseMAYO CLINIC ROCHESTER2023–2028
- Mayo Clinic HeartShare Clinical CenterMAYO CLINIC ROCHESTER2021–2026
Professional Memberships
- Fellow
- Member
- Heart Failure Society of AmericaMember
- International Society of Heart and Lung TransplantationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









